• Global Teaser

    Faculty

CPM Pharma - Faculty

An exceptional pool of trainers!

Our faculty consists of dedicated pricing expert trainers with a proven successful pricing and market access record. All trainers are excited to train on the EPP CPM® Pharma because participants are an exceptional group of pricing practitioners on their path to increase the pricing maturity of their organisations.   You can be assured that your faculty comes from a selected group of internatinal experienced pharma pricing experts, open to share and discuss the best pricing practices with you.

All CPM® trainers know how to train pricing.  They are experienced in training groups for high impact.

Your faculty :

 

Marc Abels - Partner - Monitor Deloitte

Marc has 17 years of experience in Go to market strategies and a deep expertise in pricing.  He leads the Strategy department (80 consultants) for Deloitte Belgium.   He is one of the ‘pricing’ experts within Deloitte Europe and is a regular speaker on various pricing conferences (e.g. European Pricing Platform).   His main industry focus is on Lifesciences (Pharma, MedTech).

 

Paolo Correale - Principal at Bionexa 

Paolo is Principal at Bionexa, boutique consulting dedicated to Life Sciences & Healthcare. He has been working as a consultant in Life Sciences and Healthcare for more than ten years, ranging across most functional areas. Over the past five years, Paolo has focused on designing and implementing Pricing, Market Access and Healthcare Partnership solutions for leading MedTech and Pharma players, at both global and local level.

In particular, he supported several multinationals in launching processes, organization and technology to manage all aspects of Pricing, from strategy to execution. His current interest is pioneering innovative pricing models and integrated product-service solutions across the care continuum, facilitating partnerships among Life Sciences companies, Healthcare providers and payers.

 

 

Alla Uhrlandt - Director Strategic Pricing EMEA - Janssen Pharmaceutical, Johnson & Johnson

Alla has 15 years of international working experience in market access, commercial excellence and sales functions in Medical Devices and Pharmaceutical industries. Extensive experiences in Strategic Pricing & Tendering to drive profitability and enable growth. Proven track record of successfully leading cross-functional and multinational project teams. 

 

 

Guy Nuyts - Senior Director, Global Pricing - Janssen Pharmaceutical, Janssen, Johnson & Johnson

His responsibilities focus on pricing and reimbursement policies for the infectious diseases, vaccines, neuroscience and global public health portfolio. Throughout his 20 year plus career, he had different roles of increasing responsibility in health economics, pricing, real world evidence and market access, and this across several different therapeutic areas such as Pain, Gastrointestinal, Oncology and Infectious Diseases. 

He also collaborated on several organizational redesign and improvement projects to better integrate market access and pricing functions and to align with other business functions. Between 2001 and 2008, he lived and worked in NJ, US for Johnson and Johnson. 

 

Janice Haigh - VP & GLOBAL lead for pricing & market access, Parexel ACCESS CONSULTING

Janice joined Parexel in March 2017. Prior to this she was the European P&MA lead in Quintiles Advisory Services for five years

From 2006 to 20011 Janice was Senior Director Pricing and Market Access for Astellas Pharma Europe where she was responsible for

  • pricing and market access strategy for new and in-market products, working closely with brand teams and affiliates
  • price management, analysing the effect of price changes on other markets
  • managing the impact of parallel trade

Before joining Astellas, Janice worked in consultancy for 20 years, including 10 years at IMS Health/Cambridge Pharma Consultancy

We do not teach, we train and develop.
You will learn, discuss and reflect - and you will bring the learnings into action.

You want impact, you get it.